1-11 of 11
Jeffrey L Mahon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effectiveness of Nonmydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease: A Randomized Controlled Trial (Clearsight)

Selina L. Liu, John R. Gonder, Ehsan Owrangi, Neil S. Klar, Irene M. Hramiak, Artem Uvarov, Jeffrey L. Mahon
Journal: Diabetes Care
Diabetes Care 2023;46(2):399–407
https://doi.org/10.2337/dc22-0713
Published: 05 December 2022
View article titled, Effectiveness of Nonmydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease: A Randomized Controlled Trial (Clearsight)
Open the PDF for Effectiveness of Nonmydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease: A Randomized Controlled Trial (Clearsight) in another window
Journal Articles

The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months

Jay M. Sosenko, Jay S. Skyler, Craig A. Beam, David Boulware, Jeffrey L. Mahon, Jeffrey P. Krischer, Carla J. Greenbaum, Lisa E. Rafkin, Della Matheson, Kevan C. Herold, Jerry P. Palmer, the Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
Journal: Diabetes Care
Diabetes Care 2015;38(5):940–942
https://doi.org/10.2337/dc14-2787
Published: 10 March 2015
View article titled, The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months
Open the PDF for The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months in another window
Includes: Supplementary data
Journal Articles

Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies

Liping Yu, MD, David C. Boulware, MS, Craig A. Beam, PHD, John C. Hutton, PHD, Janet M. Wenzlau, PHD, Carla J. Greenbaum, MD, Polly J. Bingley, MD, Jeffrey P. Krischer, PHD, Jay M. Sosenko, MD, Jay S. Skyler, MD, George S. Eisenbarth, MD, Jeffrey L. Mahon, MD, for the Type 1 Diabetes TrialNet Study Group
Journal: Diabetes Care
Diabetes Care 2012;35(6):1213–1218
https://doi.org/10.2337/dc11-2081
Published: 11 May 2012
View article titled, Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies
Open the PDF for Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies in another window
Includes: Supplementary data
Journal Articles

Development of Autoantibodies in the TrialNet Natural History Study

Kendra Vehik, PHD, Craig A. Beam, PHD, Jeffrey L. Mahon, MD, Desmond A. Schatz, MD, Michael J. Haller, MD, Jay M. Sosenko, MD, Jay S. Skyler, MD, Jeffrey P. Krischer, PHD, for the TrialNet Natural History Study Group
Journal: Diabetes Care
Diabetes Care 2011;34(9):1897–1901
https://doi.org/10.2337/dc11-0560
Published: 19 August 2011
View article titled, Development of Autoantibodies in the TrialNet Natural History Study
Open the PDF for Development of Autoantibodies in the TrialNet Natural History Study in another window
Journal Articles

Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)

Polly J. Bingley, MD, Jeffrey L Mahon, MD, Edwin A.M. Gale, MD, for the European Nicotinamide Diabetes Intervention Trial (ENDIT) Group
Journal: Diabetes Care
Diabetes Care 2008;31(1):146–150
https://doi.org/10.2337/dc07-0103
Published: 01 January 2008
View article titled, Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)
Open the PDF for Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT) in another window
Journal Articles

The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes: Response to Bell

Charlotte G. McDonald, MD, MSC, FRCPC, Sumit R. Majumdar, MD, MPH, FRCPC, Jeffrey L. Mahon, MD, MSC, FRCPC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(2):483–484
https://doi.org/10.2337/diacare.29.02.06.dc05-2045
Published: 01 February 2006
View article titled, The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes: <subtitle>Response to Bell</subtitle>
Open the PDF for The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes: <subtitle>Response to Bell</subtitle> in another window
Journal Articles

Diabetes During Diarrhea-Associated Hemolytic Uremic Syndrome : A systematic review and meta-analysis

Rita S. Suri, MD, William F. Clark, MD, Nick Barrowman, PHD, Jeffrey L. Mahon, MD, MSC, Heather R. Thiessen-Philbrook, MMATH, M. Patricia Rosas-Arellano, MD, PHD, Kelly Zarnke, MD, MSC, Jocelyn S. Garland, MD, Amit X. Garg, MD, MA, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(10):2556–2562
https://doi.org/10.2337/diacare.28.10.2556
Published: 01 October 2005
View article titled, Diabetes During Diarrhea-Associated Hemolytic Uremic Syndrome : <subtitle>A systematic review and meta-analysis</subtitle>
Open the PDF for Diabetes During Diarrhea-Associated Hemolytic Uremic Syndrome : <subtitle>A systematic review and meta-analysis</subtitle> in another window
Journal Articles

The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes

Charlotte G. McDonald, MD, MSC, FRCPC, Sumit R. Majumdar, MD, MPH, FRCPC, Jeffrey L. Mahon, MD, MSC, FRCPC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(9):2113–2117
https://doi.org/10.2337/diacare.28.9.2113
Published: 01 September 2005
View article titled, The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes
Open the PDF for The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Maturity-Onset Diabetes of the Young (MODY) Mutation in Type 2 Diabetes and Latent Autoimmune Diabetes of the Adult

James McKinney, BSC, Henian Cao, MD, Margaret T. Behme, PHD, Jeffrey L. Mahon, MD, Robert A. Hegele, MD
Journal: Diabetes Care
Diabetes Care 2003;26(12):3358–3359
https://doi.org/10.2337/diacare.26.12.3358-a
Published: 01 December 2003
View article titled, Maturity-Onset Diabetes of the Young (MODY) Mutation in Type 2 Diabetes and Latent Autoimmune Diabetes of the Adult
Open the PDF for Maturity-Onset Diabetes of the Young (MODY) Mutation in Type 2 Diabetes and Latent Autoimmune Diabetes of the Adult in another window
Journal Articles

The Limitations of Clinical Mais for Prevention of IDDM

Jeffrey L Mahon, MD, MSC, FRCPC, John Dupre, MA, FRCPC, FRCP, FACP
Journal: Diabetes Care
Diabetes Care 1997;20(6):1027–1033
https://doi.org/10.2337/diacare.20.6.1027
Published: 01 June 1997
View article titled, The Limitations of Clinical Mais for Prevention of IDDM
Open the PDF for The Limitations of Clinical Mais for Prevention of IDDM in another window
Journal Articles

Immunosuppression in IDDM: Rationale, Risks, Benefits, and Strategies

Jeffrey L Mahon, FRCP, John Dupré, FRCP, Calvin R Stiller, FRCP, Allan P Donner, PhD
Journal: Diabetes Care
Diabetes Care 1990;13(7):806–808
https://doi.org/10.2337/diacare.13.7.806
Published: 01 July 1990
View article titled, Immunosuppression in IDDM: Rationale, Risks, Benefits, and Strategies
Open the PDF for Immunosuppression in IDDM: Rationale, Risks, Benefits, and Strategies in another window